All subcategories » published, non RCT
Health care costs in a randomized trial of antimicrobial duration among cystic fibrosis patients with pulmonary exacerbations.
primary studies published, non RCT
Details- 2022
- Gold LS
Impact of pharmacy services on time to elexacaftor-tezacaftor-ivacaftor initiation.
primary studies published, non RCT
Details- 2022
- Roder L
Feasibility and efficacy of combined pancreatic islet-lung transplantation in cystic fibrosis related diabetes -PIM study: a multicenter phase 1-2 trial.
primary studies published, non RCT
Details- 2022
- Rakotoarisoa L
The Effect of Control IQ Hybrid Closed Loop Technology on Glycemic Control in Adolescents and Adults with Cystic Fibrosis-Related Diabetes.
primary studies published, non RCT
Details- 2022
- Scully KJ
The Short Term Influence of Chest Physiotherapy on Lung Function Parameters in Children With Cystic Fibrosis and Primary Ciliary Dyskinesia.
primary studies published, non RCT
Details- 2022
- Vandervoort B
The Role of Bronchoscopy in the Management of Children With Cystic Fibrosis.
primary studies published, non RCT
Details- 2022
- Tosco A
Maternal and fetal outcomes following elexacaftor-tezacaftor-ivacaftor use during pregnancy and lactation.
primary studies published, non RCT
Details- 2021
- Taylor-Cousar JL
Lumacaftor/ivacaftor in cystic fibrosis: effects on glucose metabolism and insulin secretion.
primary studies published, non RCT
Details- 2021
- Colombo C
Clinical Effectiveness of Elexacaftor/Tezacftor/Ivacaftor in People with Cystic Fibrosis.
primary studies published, non RCT
Details- 2021
- Nichols DP
The long-term safety of chronic azithromycin use in adult patients with cystic fibrosis, evaluating biomarkers for renal function, hepatic function and electrical properties of the heart.
primary studies published, non RCT
Details- 2021
- Akkerman-Nijland AM